Description
Product Overview
TB-500 5 mg is a laboratory-supplied research peptide provided in lyophilized powder form and manufactured to research-grade purity standards. Each vial is sealed to preserve compound integrity, stability, and consistency, supporting accurate handling and reproducible results within controlled laboratory research environments.
In non-clinical research settings, TB-500 is commonly referenced in experimental and analytical studies examining peptide–actin interactions, intracellular structural dynamics, and cytoskeletal-related signaling mechanisms under defined in vitro conditions. As a synthetic peptide corresponding to a fragment of thymosin beta-4, TB-500 features a well-characterised molecular structure that supports its use as a reference compound in peptide research, assay validation, and exploratory laboratory investigations.
This product is supplied exclusively for laboratory research use. It is not approved for human or veterinary administration, medical treatment, or diagnostic purposes and must be handled only by qualified professionals in accordance with applicable laboratory regulations.
Research Background
TB-500 is a synthetic peptide widely referenced in preclinical and laboratory research literature focused on actin-binding behavior, cytoskeletal organization, and peptide-mediated cellular interaction models. In controlled, non-clinical research environments, TB-500 is utilised to investigate peptide protein binding dynamics, intracellular structural response mechanisms, and molecular interaction pathways in in vitro systems.
Due to its defined amino acid sequence and documented presence in experimental research, TB-500 is frequently included in laboratory studies examining peptide structure function relationships and cytoskeletal-associated signaling behavior under controlled conditions.
Research Characteristics (Non-Therapeutic)
- Referenced in cytoskeletal and actin-interaction research
- Suitable for controlled laboratory and in vitro investigations
- Lyophilized format supporting compound stability and consistency
- Defined molecular profile for reproducible analytical outcomes
- Intended for professional laboratory research use only
Product Specifications
- Compound: TB-500 (Thymosin Beta-4 Fragment)
- Quantity: 5 mg per vial
- Form: Lyophilized powder
- Appearance: White to off-white solid
- Purity: Research-grade (see Certificate of Analysis where available)
- Packaging: Sealed laboratory research vial
Storage & Handling
Store the lyophilized compound at 28°C to maintain optimal stability. For long-term storage, freezing may be applied where appropriate. Protect from light, heat, and moisture. Once handled or prepared for research purposes, follow established laboratory protocols for storage, usage, and disposal in compliance with applicable regulations.
admin –
We’ve been bringing in TB-500 for ongoing research work, and this batch from the current supplier has been consistent with what we expect at scale. Vials arrived well-packaged, clearly labeled, and accompanied by documentation without needing multiple follow-ups. That alone puts them ahead of a lot of vendors we’ve dealt with.
From a handling standpoint, reconstitution was straightforward and the material behaved consistently across multiple runs. We’ve seen less variability compared to some previous sources, which is important when you’re working through larger sequences of testing.
We’re based in Delaware and typically order in bulk, so reliability on fulfillment matters—so far, they’ve been on point with timelines and order accuracy. Feels more like working with a direct manufacturer than a middleman.
Distefano, Delaware (USA)